CBD for Peripheral Neuropathy: How Does It Work?
by Bethan Rose
A lot of women experience what is referred to as ‘morning sickness’ during pregnancy. This is when the pregnancy causes nausea and vomiting, typically occurring at any part of the day despite its name. However, many women don’t know that there is an extreme version of morning sickness which can be devastating to the mother and the child. Researchers Gideon Koren and Rana Cohen have found promise in the effectiveness of cannabis for this extreme condition known as Hyperemesis Gravidarum.
The HER Foundation explains Hyperemesis Gravidarum (HG) as a potentially life-threatening pregnancy disease that causes extreme morning sickness. HG causes weight loss, malnutrition, dehydration, and debility because of the severe vomiting and nausea associated with HG. The disease may even lead to long-term problems for the mother and her baby(ies).
HG and morning sickness have relations with the body’s human chorionic gonadotropin (hCG), which is a hormone created by the placenta as a result of being pregnant. The body produces a significant amount of this hormone and a fast rate early in the pregnancy, then these levels continue to increase as the pregnancy continues. However, the exact cause of the nausea and vomiting during pregnancy is not certain.
While morning sickness and HG might sound like similar conditions because of the shared symptoms of nausea and vomiting, they are in fact quite different.
Morning sickness includes nausea and vomiting, which may be discomforting but is mostly manageable and does not leave the mother with severe dehydration. The symptoms of morning sickness also tend to disappear around weeks 12-14 of pregnancy and they do not remain present consistently. While morning sickness may cause fatigue and a slight loss of appetite, it is not enough to cause major interference with daily activities.
Hyperemesis Gravidarum includes nausea and vomiting from morning sickness but it tends not to go away and it can lead to severe dehydration. As you can imagine, this would make it rather challenging for these soon-to-be-mothers to keep down food and fluids vital to the baby(ies). Along with the reduced ability to take in nutrients, HG can be extremely debilitating and it can lead to fatigue which can last for several weeks or even months. Women with Hyperemesis Gravidarum also tend to lose their entire appetite. All of this considered, the women with HG then experience (1) the struggle to work and do daily activities, (3) dehydration and malnutrition as well as (4) struggle to gain weight or may even lose weight despite having a baby growing in their belly.
The HER foundation explains that just under half of the women with Hyperemesis Gravidarum experience the symptoms for their entire pregnancy.
If the mother’s symptoms are severe, the fetal can be lost or risks future issues such as infection, early delivery, congenital heart disease, skin abnormalities, low birth weight, undescended testicles, perinatal death, behavior disorders, sensory disorders, and even skeletal malformations. However, the long term effects are not certain due to research finding inconsistency in the long-term implications of Hyperemesis Gravidarum.
The 2020 published research of Gideon Koren and Rana Cohen explains that HG responds partially to antiemetic medications and that cannabis possesses antiemetic effects. Antiemetic medications are used to fight against vomiting and nausea. The team took to evaluating women with HG who were counseled by the Motherisk Program before and after consuming cannabis for the symptoms by means of a validated Pregnancy Unique Quantification of Emesis (PUQE) scoring system. The PUQE evaluates the severity of nausea and vomiting during pregnancy based on three criteria being (1) nausea, (2) vomiting, and (3) retching.
The study found a significant improvement in the symptoms as well as the quality of life in the participants. The PUQE scores improved from 14.5 (upper range of severity) down to 7.5 (moderate severity). This comes after being administered cannabis with a 20% tetrahydrocannabinol (THC) quantity with only traces of CBD. The team also reported that this cannabis combo had a significant impact on the severity of the condition in the form of reducing it. By reducing the severity of the condition, the mother and child are exposed to less risk of long-term effects as well as malnutrition, dehydration, and weight-loss.
The team also referred to a survey conducted in British Columbia which reported that “of 79 pregnant respondents, 51 (65%) reported using cannabis during their pregnancies. While 59 (77%) of the respondents who had been pregnant had experienced nausea and/or vomiting of pregnancy, 40 (68%) had used cannabis to treat the condition, and of these respondents, 37 (over 92%) rated cannabis as ‘extremely effective’ or ‘effective’”.
With Hyperemesis Gravidarum being such a potentially threatening condition, it is important to explore all avenues which may offer some relief. Fortunately enough, cannabis has become well known for its ability to alleviate nausea and vomiting and has now been shown to also reduce the severity of conditions such as Hyperemesis Gravidarum. Although, treating HG with cannabis may require some experimentation as women need to find the cannabis strain which offers them the optimal amount of relief, keeping in mind that it should contain THC (as per the study). At this time, research is still much needed in terms of using cannabis during pregnancy and it has not officially been deemed safe. Therefore, it is incredibly important for pregnant people with Hyperemesis Gravidarum to openly consult with their medical physicians over the use of cannabis, or to find a doctor that will be able to consult them on the way forward with cannabis as a treatment.
Cannabis’ former reputation as a gateway drug may have been dispelled, but it turns out that there is some element of truth to the rumor: The plant’s progressively evolving status as a normalized medicine in 37 U.S. states and a recreational substance in 18 U.S. states is prompting a wave of change across America’s statehouses….
Researchers working at the University of Arizona College of Medicine in Tucson have refined a method of ketamine use in the treatment of Parkinson’s disease (PD). Specifically, the group focused on ketamine’s ability to relieve the side effects of a common treatment called Levodopa. Nicknamed “K,” “special K,” “cat valium,” and “vitamin K,” ketamine is…
Austin decriminalized cannabis possession, Vancouver is now home to some not-so-legal magic mushroom shops, and a British woman shared her life-changing medical marijuana journey. Let’s dive into this week’s cannanews. Austin Voters Pass Cannabis Decriminalization Bill Voters in Austin, Texas, have approved Proposition A, a ballot measure that decriminalizes cannabis possession and bans no-knock warrants….
The worldwide skincare industry, which is projected to inflate to $189.3 billion USD by 2025, could soon be merging more closely with cannabis. In particular, the cannabis plant’s non-intoxicating compound cannabidiol (CBD) is grasping the attention of experts in this field of work for its ability to amplify the effects of retinol. Retinol, a fat-soluble…
As if losing a limb is not hard enough, experiencing pain in the part of the limb that is no longer there acts as a constant reminder of what has been lost on top of the actual pain. Phantom limb pain (PLP) plagues an estimated 8 out of 10 people who have lost a limb,…
Research reveals that cannabis can impact male reproductive health through reprogramming sperm, which may have implications for any baby born from such…
Woody Harrelson’s new dispensary opened for business, Thailand announced its giveaway of 1 million cannabis plants, and Vermont awarded its first cannabis…
There’s no denying the fact that CBD is dominating the wellness landscape. Increasing awareness of the cannabinoid’s medicinal effects is going hand-in-hand…